Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-17-013549
Filing Date
2017-10-30
Accepted
2017-10-30 21:19:57
Documents
1
Period of Report
2017-10-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 5993
  Complete submission text file 0001179110-17-013549.txt   7515
Mailing Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400
Business Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400 (216) 523-5000
Allergan plc (Issuer) CIK: 0001578845 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address
DArecca James (Reporting) CIK: 0001583903 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36867 | Film No.: 171163857